WHO ICTRP trial
N-acetylcysteine in heavy smokers: A double-blind randomized controlled trial.
NL-OMON21561 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON21561 |
|---|---|
| Public title | N-acetylcysteine in heavy smokers: A double-blind randomized controlled trial. |
| Scientific title | N-acetylcysteine in heavy smokers: A double-blind randomized controlled trial. |
| Primary sponsor | Academic Medical Center (AMC) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | nicotine dependence |
| Interventions | 1. 4 day administration of 3600 mg of N-acetylcysteine; 2. 4 day administration of placebo. |
| Registration date | Feb 8, 2010 |
| Target size | 20 |
| Secondary IDs | NL2086;NTR2204; : ;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: